• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Approves Genzyme ’s Cerdelga™ (eliglustat) Capsules

    FDA Approves Genzyme ’s Cerdelga™ (eliglustat) Capsules

  2. Genzyme Receives Label Expansion for Lumizyme® (alglucosidase alfa) in the United States for the treatment of Pompe Disease

    Genzyme Receives Label Expansion for Lumizyme® (alglucosidase alfa) in the United States for the treatment of Pompe Disease

  3. Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

    Sanofi Gets U.S. FDA Approval for Gaucher Disease Treatment

  4. Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy

    Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy

  5. Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update

    Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update

  6. Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy

    Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy

  7. Sanofi H1 2014 Results - Interview with Chris Viehbacher

    Sanofi H1 2014 Results - Interview with Chris Viehbacher

  8. CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China

    CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China

  9. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.